Improving care for patients with extrapulmonary tuberculosis
Official title: A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary Tuberculosis
Run by University of Cologne · NCT06875336 · Data updated 2026-11-12
This study is trying to improve care for adults newly diagnosed with extrapulmonary tuberculosis by collecting their health information and samples to better understand the disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | University of Cologne Academic / other |
| Locations | 6 sites (Bonn and 5 other locations) |
| Status | Recruiting |
| Started | March 6, 2023 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | March 13, 2025 |
| Trial ID | NCT06875336 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who have been newly diagnosed with extrapulmonary tuberculosis.
✕Probably not a fit
Patients under 18 years of age or those with conditions that may interfere with study participation will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicentric observational study focuses on adult patients newly diagnosed with extrapulmonary tuberculosis (EPTB). Participants will be enrolled prospectively, and their clinical data will be collected through standardized questionnaires throughout their treatment. Additionally, body fluids such as blood and urine will be collected for biomarker analysis, which will be correlated with clinical data to enhance understanding of EPTB. A healthy control group will also be included for technical comparisons in laboratory analyses.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic and treatment strategies for patients with extrapulmonary tuberculosis.
How similar studies have gone: Other studies have shown success in using biomarker analysis for tuberculosis, but this specific approach focusing on extrapulmonary cases is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 18 years 2. Isolation of Mycobacterium tuberculosis complex from a bodily secretion or tissue by 1. PCR 2. culture or a presumptive clinical diagnosis based on epidemiologic exposure in combination with physical findings, radiographic findings and/or histopathology 3. Patients with extrapulmonary TB * pleura * lymph nodes * bones and joints * larynx * pericardial * parotid gland * abdominal sites * kidneys * genitourinary tract * disseminated (miliary) TB * other than pulmonary TB 4. In the case of pulmonary and extrapulmonary involvement, the leading manifestation, clinically and radiographically, must be extrapulmonary. 5. Written informed consent provided prior to inclusion Exclusion Criteria: * 1\. Age \<18 years 2. Patient with any social or logistical condition which, as anticipated by the investigator, may interfere with the conduct of the study, such as incapacity to well understand the study content and procedure (in case of any language barriers, a translator may be involved), not willing to collaborate, or anticipated inability to finish study due to physical weakness 3. Dependencies towards the study team (e.g. family members, employees of the same department) 4. Pregnant women 5. Patient in custodianship or guardianship 6. Leading pulmonary manifestation 7. Solitary CNS tuberculosis Patients may take part in other clinical studies and trials, as long as there is no conflict with the inclusion or exclusion criteria of the mEX-TB study and the protocol of the other study or trial does not conflict with the means of data and sample collection and publication of this protocol.
Where it's running
-
Research Center Borstel
Borstel, Germany Recruiting -
University Hospital of Cologne
Cologne, Germany Recruiting -
University Hospital Hamburg
Hamburg, Germany Recruiting -
University Hospital Heidelberg
Heidelberg, Germany Recruiting -
University Hospital Bonn
Bonn, Germany Not yet recruiting -
University Hospital Frankfurt
Frankfurt, Germany Not yet recruiting
Study contacts
- Study coordinator: Isabelle Suarez, Dr
- Email: isabelle.suarez@uk-koeln.de
- Phone: +49 (221) 478-39680
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Biomarker Test for Diagnosis and Monitoring of Extrapulmonary Tuberculosis
This study tests biomarker-based methods to help diagnose extrapulmonary TB and monitor treatment in adults, including people living with HIV, using samples from affected sites in Kenya.
-
Dapagliflozin to slow kidney decline in autosomal dominant polycystic kidney disease
This will test if taking dapagliflozin every day slows kidney function loss in adults 18–60 with rapidly progressing ADPKD.
-
Understanding vaccine responses in immunocompromised patients
This study looks at how well vaccines work for people with weakened immune systems, like those with blood cancers or on certain treatments, to help improve their protection against respiratory viruses.
-
Comparing cataract surgery with a new corneal transplant technique for patients with cataracts and Fuchs dystrophy
This study is testing whether a new corneal transplant technique combined with cataract surgery can improve vision and quality of life for people with cataracts and Fuchs dystrophy compared to standard cataract surgery alone.
-
Managing sodium levels in patients with severe kidney disease
This study tests how giving water and salt to adults with severe kidney disease can help balance their sodium levels and improve their health.
-
Skin-to-skin contact for preterm infants at birth
This study is testing whether immediate skin-to-skin contact after birth can help moderate and late preterm infants develop better and cope with stress.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.